The quantitative PCR analysis showed that neither Bcl-2 nor Bax expression levels were affected by the presence of tumor cell-derived exosomes (Fig 2D and 2E), indicating that the decrease in osteoclast formation seen with tumor cell exosome-treated RAW264.7 cells could not be explained by induction of apoptosis. This evidence concerns the gene BCL2 and neoplasm.